Indian equity markets ended lower on August 31, responding to prevailing global economic dynamics. A modest decline in the Nifty50 index br...

Maharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized ...

Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized th...

A reactor blast at a pharma company in Telangana's Yadadri Bhuvanagiri district killed two workers. Nine other individuals sustained injuri...

Maharashtra Food and Drug Administration (FDA) Commissioner Tukaram Mundhe on Tuesday said strict action would be taken against violations ...

Current government procurement policies can obstruct innovation, often favouring established firms. Furthermore, major Indian corporations ...

The ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...

Demand for nutrition professionals is rapidly rising across India. Hospitals and digital health platforms are hiring more dietitians and ed...

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...

The government told Parliament it is closely monitoring developments in its trade relationship with the US and remains engaged with Washing...

Under the India-Britain CETA, Indian exporters could tap into new market avenues, with Britain's Department of International Trade predicti...

Financial services is where FIIs go when they turn positive on India. History shows us that much of the money goes to banks, and the wider ...

Markets traded subdued on the weekly expiry day, with indices ending marginally lower. Cochin Shipyard's offer for sale saw strong investor...

India will deploy AI passenger profiling and drug screening in educational institutions. This national roadmap aims to combat drug traffick...

New rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...

Indian Ambassador Vikram Doraiswami met a senior Chinese Commerce Ministry official to boost trade and commercial cooperation. The discussi...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...